These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1967858)
41. Epstein-Barr virus--associated posttransplant lymphoproliferative disorder presenting as perirenal transplant lymphocele. Squiers EC; West JC; Leonard D; Latsha R; Miller J; Fetterolf N; Kelley SE; Tyler W Transplantation; 1993 Nov; 56(5):1278-9. PubMed ID: 8249138 [No Abstract] [Full Text] [Related]
42. Epstein-Barr virus. A serial killer or an innocent bystander? Sangüeza OP Arch Dermatol; 1997 Sep; 133(9):1156-7. PubMed ID: 9301594 [No Abstract] [Full Text] [Related]
43. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder. Lager DJ; Burgart LJ; Slagel DD Mod Pathol; 1993 Jan; 6(1):42-7. PubMed ID: 8381232 [TBL] [Abstract][Full Text] [Related]
44. Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. Eisen HJ; Hicks D; Kant JA; Montone KT; Mull R; Pigott J; Tomaszewski JE J Heart Lung Transplant; 1994; 13(2):241-5. PubMed ID: 8031806 [TBL] [Abstract][Full Text] [Related]
45. Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Schmidtko J; Wang R; Wu CL; Mauiyyedi S; Harris NL; Della Pelle P; Brousaides N; Zagachin L; Ferry JA; Wang F; Kawai T; Sachs DH; Cosimi BA; Colvin RB Transplantation; 2002 May; 73(9):1431-9. PubMed ID: 12023621 [TBL] [Abstract][Full Text] [Related]
46. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. Mañez R; Breinig MC; Linden P; Wilson J; Torre-Cisneros J; Kusne S; Dummer S; Ho M J Infect Dis; 1997 Dec; 176(6):1462-7. PubMed ID: 9395355 [TBL] [Abstract][Full Text] [Related]
50. Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. Cacciarelli TV; Reyes J; Mazariegos GV; Sigurdsson L; Rowe DT; Fung JJ; Green M Transplant Proc; 1999; 31(1-2):488-9. PubMed ID: 10083204 [No Abstract] [Full Text] [Related]
51. Involvement of the gastrointestinal tract by Epstein-Barr virus--associated posttransplant lymphoproliferative disorders. Nalesnik MA Am J Surg Pathol; 1990; 14 Suppl 1():92-100. PubMed ID: 2158245 [TBL] [Abstract][Full Text] [Related]
52. Immunological aspects of a case of posttransplant lymphoproliferative disorder. Franco A; Muñoz C; Aranda I; Cabezas A; Perdiguero M; Prados C Am J Nephrol; 1995; 15(2):137-41. PubMed ID: 7733150 [TBL] [Abstract][Full Text] [Related]
53. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft. Hegele RG; Bicknell SG; Bailey DJ; Cameron RG Arch Pathol Lab Med; 1994 Aug; 118(8):795-6. PubMed ID: 8060227 [TBL] [Abstract][Full Text] [Related]
54. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725 [TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. Bar-Natan M; Nagler A Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060 [No Abstract] [Full Text] [Related]
56. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304 [TBL] [Abstract][Full Text] [Related]
57. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198 [TBL] [Abstract][Full Text] [Related]
58. Post-transplantation lymphoproliferative disorder of the T-cell/B-cell type: an unusual manifestation in a renal allograft. Wirnsberger GH; Ratschek M; Dimai HP; Holzer H; Mandal AK Oncol Rep; 1999; 6(1):29-32. PubMed ID: 9864396 [TBL] [Abstract][Full Text] [Related]
59. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy. Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG; Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361 [TBL] [Abstract][Full Text] [Related]
60. Multiple leiomyosarcomas of both donor and recipient origin arising in a heart-lung transplant patient. Somers GR; Tesoriero AA; Hartland E; Robertson CF; Robinson PJ; Venter DJ; Chow CW Am J Surg Pathol; 1998 Nov; 22(11):1423-8. PubMed ID: 9808136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]